News | January 29, 2022
DCGI approves Bharat Biotech’s Phase 3 trials for intranasal vaccine
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
It would be the first protein-based alternative available in Israel
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
The vaccines are currently only authorised for emergency use in the country
Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
Subscribe To Our Newsletter & Stay Updated
